A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
Clinical trial NCT00791232 · COMPLETED
Trial details
- NCT number
- NCT00791232
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.